Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Short and medium term results of the surgical management of ileocecal Crohn's disease].

Revista medica de Chile·2023
Same author

[Outcome of surgery for Crohn's colitis. Review of 28 cases].

Revista medica de Chile·2018
Same author

[Transesophageal echocardiography to monitor fluid administration during the perioperative period].

Revista medica de Chile·2012
Same author

[Serial transverse enteroplasty for short bowel syndrome. Case report].

Revista medica de Chile·2010
Same author

Modified loose-seton technique for the treatment of complex anal fistulas.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2010
Same author

[Pulmonary and gastric sarcoidosis. Report of one case].

Revista medica de Chile·2009
Same journal

[Health Education for Informed Autonomy: When to Begin?]

Revista medica de Chile·2026
Same journal

[Open Atrial Transcatheter Mitral Valve Replacement for Mitral Annular Calcification: First Case Report in Chile].

Revista medica de Chile·2026
Same journal

[From Opinion to Structure: The Role of Different Types of Systematic Reviews Within the Evidence Synthesis Ecosystem].

Revista medica de Chile·2026
Same journal

[Neuropsychiatric Effects of Creatine: What Does the Preclinical and Clinical Evidence Conclude?]

Revista medica de Chile·2026
Same journal

[Ethical Issues in Early Serological Diagnosis of Alzheimer's Disease].

Revista medica de Chile·2026
Same journal

[Weight Recurrence After Bariatric Surgery: Definitions, Diagnosis, and Management Strategies. Part 1].

Revista medica de Chile·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
07:38

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

[Active and refractory ulcerative proctitis: an update].

Gino Caselli M1, George Pinedo M, Alvaro Zúñiga D

  • 1Unidad de Cirugía Colorrectal, Hospital Clínico, Pontificia Universidad Católica de ChileChile.

Revista Medica De Chile
|April 3, 2010
PubMed
Summary
This summary is machine-generated.

Topical 5-aminosalicylates (5-ASA) effectively induce and maintain remission for ulcerative proctitis (UP). For refractory cases, alternative therapies including oral 5-ASA, corticosteroids, and biologics offer further treatment options.

Related Experiment Videos

Last Updated: Jun 14, 2026

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
07:38

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

Area of Science:

  • Gastroenterology
  • Inflammatory Bowel Disease Research
  • Colorectal Health

Context:

  • Ulcerative colitis (UC) is a chronic inflammatory condition affecting the colon.
  • Ulcerative proctitis (UP) is a subtype of UC limited to the rectum.
  • Etiology and factors influencing UC extent remain largely unknown.

Purpose:

  • To outline therapeutic goals for UP, focusing on symptom and disease remission.
  • To review current treatment strategies for inducing and maintaining remission in UP.
  • To identify alternative therapies for UP patients unresponsive to initial treatments.

Summary:

  • Topical 5-aminosalicylates (5-ASA) are the primary treatment for inducing remission in UP.
  • Long-term 5-ASA therapy is superior to placebo for maintaining inactive disease in UP.
  • For moderate-to-severe or refractory UP, options include oral 5-ASA, corticosteroids, immunomodulators, biologics (e.g., Infliximab), and cyclosporine.

Impact:

  • Provides a clear treatment pathway for ulcerative proctitis management.
  • Highlights the efficacy of topical 5-ASA in inducing and maintaining remission.
  • Informs clinical decision-making for advanced or non-responsive UP cases, reducing the need for surgery.